Preclinical evaluation of the novel [18F]CHDI-650 PET ligand for non-invasive quantification of mutant huntingtin aggregates in Huntington's disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Preclinical evaluation of the novel [18F]CHDI-650 PET ligand for non-invasive quantification of mutant huntingtin aggregates in Huntington's disease ; day:27 ; month:8 ; year:2024 ; pages:1-12
European journal of nuclear medicine and molecular imaging ; (27.8.2024), 1-12
- Urheber
-
Zajicek, Franziska
Verhaeghe, Jeroen
Lombaerde, Stef De
Eetveldt, Annemie Van
Miranda, Alan
Munoz-Sanjuan, Ignacio
Dominguez, Celia
Khetarpal, Vinod
Bard, Jonathan
Liu, Longbin
Staelens, Steven
Bertoglio, Daniele
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-024-06880-x
- URN
-
urn:nbn:de:101:1-2411130729548.306537085060
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zajicek, Franziska
- Verhaeghe, Jeroen
- Lombaerde, Stef De
- Eetveldt, Annemie Van
- Miranda, Alan
- Munoz-Sanjuan, Ignacio
- Dominguez, Celia
- Khetarpal, Vinod
- Bard, Jonathan
- Liu, Longbin
- Staelens, Steven
- Bertoglio, Daniele
- SpringerLink (Online service)
Ähnliche Objekte (12)
Soluble mutant huntingtin drives early human pathogenesis in Huntington’s disease
HAP40 modulates mutant Huntingtin aggregation and toxicity in Huntington’s disease mice
Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington’s disease patients
Analysis of mutant and total huntingtin expression in Huntington’s disease murine models
Mutant huntingtin induces iron overload via up-regulating IRP1 in Huntington’s disease
Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington’s disease
Analysis of mutant huntingtin aggregation and toxicity in Drosophila models of Huntington’s disease
Mutant huntingtin confers cell-autonomous phenotypes on Huntington’s disease iPSC-derived microglia
Inducible mutant huntingtin expression in HN10 cells reproduces Huntington's disease-like neuronal dysfunction
Discovery of an autophagy inducer J3 to lower mutant huntingtin and alleviate Huntington’s disease-related phenotype
Preventing mutant huntingtin proteolysis and intermittent fasting promote autophagy in models of Huntington disease
TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease models
Soluble mutant huntingtin drives early human pathogenesis in Huntington’s disease
HAP40 modulates mutant Huntingtin aggregation and toxicity in Huntington’s disease mice
Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington’s disease patients
Analysis of mutant and total huntingtin expression in Huntington’s disease murine models
Mutant huntingtin induces iron overload via up-regulating IRP1 in Huntington’s disease
Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington’s disease
Analysis of mutant huntingtin aggregation and toxicity in Drosophila models of Huntington’s disease
Mutant huntingtin confers cell-autonomous phenotypes on Huntington’s disease iPSC-derived microglia
Inducible mutant huntingtin expression in HN10 cells reproduces Huntington's disease-like neuronal dysfunction
Discovery of an autophagy inducer J3 to lower mutant huntingtin and alleviate Huntington’s disease-related phenotype
Preventing mutant huntingtin proteolysis and intermittent fasting promote autophagy in models of Huntington disease
TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease models
Soluble mutant huntingtin drives early human pathogenesis in Huntington’s disease
HAP40 modulates mutant Huntingtin aggregation and toxicity in Huntington’s disease mice
Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington’s disease patients
Analysis of mutant and total huntingtin expression in Huntington’s disease murine models
Mutant huntingtin induces iron overload via up-regulating IRP1 in Huntington’s disease
Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington’s disease
Analysis of mutant huntingtin aggregation and toxicity in Drosophila models of Huntington’s disease
Mutant huntingtin confers cell-autonomous phenotypes on Huntington’s disease iPSC-derived microglia
Inducible mutant huntingtin expression in HN10 cells reproduces Huntington's disease-like neuronal dysfunction
Discovery of an autophagy inducer J3 to lower mutant huntingtin and alleviate Huntington’s disease-related phenotype
Preventing mutant huntingtin proteolysis and intermittent fasting promote autophagy in models of Huntington disease